製薬品質管理の世界市場

製薬品質管理の世界市場は2030年までに36億米ドルに到達

2024年に18億米ドルと推定される製薬品質管理の世界市場は、2024年から2030年にかけてCAGR 13.0％で成長し、2030年には36億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである消耗品は、CAGR 12.4％を記録し、分析期間終了時には23億米ドルに達すると予測されます。機器セグメントの成長率は、分析期間でCAGR 14.7％と推定されます。

米国市場は4億7,730万米ドルと推定、中国はCAGR17.3％で成長予測

米国の製薬品質管理市場は、2024年には4億7,730万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを17.3%として、2030年までに7億6,490万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.5％と11.5％と予測されています。欧州では、ドイツがCAGR 10.3%で成長すると予測されています。

世界の製薬品質管理市場- 主要動向と促進要因のまとめ

なぜ品質管理が医薬品製造の成功の要になりつつあるのか？

規制の厳しい医薬品セクターにおいて、品質管理（QC）は製品の有効性、安全性、規制遵守を守るための基本的なものです。品質管理には、原料試験、工程内サンプリング、最終製品分析、環境モニタリングなど、さまざまな活動が含まれ、各バッチが厳格な薬局方基準や事前定義された仕様に適合していることを保証します。規制当局が製造慣行と製品の品質に対する監視を強化する中、QCプロセスは分析技術、リスクベースのプロトコル、およびデジタル統合によって強化されています。

最新の医薬品、特に生物製剤、ワクチン、細胞・遺伝子治療薬は複雑であるため、重要な品質特性（CQA）をモニターするための高感度で専門的なQC手法が必要とされています。このため、QCラボでは高速液体クロマトグラフィー（HPLC）、分光法、質量分析法、迅速微生物学的手法が広く採用されるようになっています。さらに、リアルタイム・リリース・テスト（RTRT）と継続的プロセス検証の重視により、品質管理は最終チェックポイントから、生産サイクル全体にわたる統合的でプロアクティブな品質保証機能へと移行しつつあります。

高度な分析技術と自動化は、QCの効率と精度をどのように高めているのか？

高度な分析機器と自動化されたワークフローの統合により、製薬品質管理は、労働集約的なバッチ駆動モデルから、合理化された高スループットオペレーションへと変貌しつつあります。サンプル調製、データ収集、結果報告の自動化は、所要時間を短縮し、ヒューマンエラーを最小限に抑え、トレーサビリティを向上させています。ロボット・サンプリング・システム、インテリジェント・データ分析プラットフォーム、LIMSの統合により、検査室はより大量のサンプルをより高い精度と規制遵守で処理できるようになっています。

近赤外（NIR）分光法、ラマン分光法、ケモメトリック・モデリングなどの技術は、固形製剤やバイオ医薬品のリアルタイム非破壊分析を可能にしています。製造ラインに組み込まれたプロセス分析技術（PAT）ツールは現在、CQAをリアルタイムで監視・管理するために使用されており、エンドポイント試験への依存を減らしています。これらの技術革新は、バッチサイズが小さく、タイムラインが圧縮され、製品の一貫性が重要な連続製造や個別化医療において特に重要です。

なぜ世界の規制、コスト圧力、デジタル化の動向がQC戦略を変えているのか？

FDA、EMA、WHOの規制要件は、Quality-by-Design（QbD）やライフサイクルベースのアプローチへと進化しており、QCデータを上流および下流の工程管理と統合するよう企業に促しています。当局は現在、検査手法の強固な文書化、データのトレーサビリティ、リアルタイムでの管理戦略の証拠を期待しています。このようなシフトにより、製薬会社はコンプライアンス追跡を一元化し、遠隔監査をサポートするデジタル品質管理プラットフォームにQCシステムを組み込むよう促されています。

医薬品製造におけるコスト圧力も、特にジェネリック医薬品や受託製造事業におけるQC戦略に影響を与えています。企業は、品質を損なうことなくリソースの利用を最適化するために、マルチ分析プラットフォーム、集中検査施設、遠隔データレビューシステムに投資しています。デジタルトランスフォーメーションにより、AIや機械学習ツールによる予測分析、傾向検出、逸脱管理が可能になり、従来の品質保証のパラダイムを超えた、プロアクティブで適応性のあるQC機能が構築されつつあります。

製薬品質管理市場の世界的成長の原動力は？

製薬品質管理市場の成長は、医薬品の複雑性の増加、規制枠組みの進化、連続的かつ精密な製造へのシフトなど、いくつかの要因によってもたらされます。主な成長要因は、世界なサプライチェーンの多様化と技術革新サイクルの速いペースに直面する中で、製品の完全性、患者の安全性、コンプライアンスを確保する必要性です。

業界が生物製剤、バイオシミラー、先端治療薬の規模を拡大するにつれて、正確で高感度、標準化されたQC技術への需要が高まっています。同時に、医薬品製造の世界化とアウトソーシングの動向は、地域間で調和され検証された品質管理システムの必要性を生み出しています。デジタル品質エコシステム、自動化技術、迅速な分析手法の拡大は、QCを世界中の医薬品製造におけるリスク軽減、規制上の成功、オペレーショナル・エクセレンスの中心となる戦略的機能へと進化させ続けると思われます。

セグメント

製品タイプ（無菌試験、バイオバーデン試験、エンドトキシン試験、安定性試験、抽出・溶出性試験、原料試験、その他の分析タイプ）

調査対象企業の例（注目の33社）

• bioMerieux SA
• BRAM-COR SPA
• Charles River Laboratories International Inc.
• Danaher Corporation
• Esco Micro Pte. Ltd.
• Eurofins Scientific
• Lucideon Limited
• Merck KGaA
• Mettler Toledo
• Panomex Inc.
• PerkinElmer Inc.
• REMI Group
• Sartorius AG
• SGS S.A.
• Shimadzu Scientific Instruments
• Solvias AG
• Thermo Fisher Scientific Inc.
• Toxikon Corporation
• Waters Corporation
• WuXi AppTec

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Pharmaceutical Quality Control Market to Reach US$3.6 Billion by 2030

The global market for Pharmaceutical Quality Control estimated at US$1.8 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 13.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 14.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$477.3 Million While China is Forecast to Grow at 17.3% CAGR

The Pharmaceutical Quality Control market in the U.S. is estimated at US$477.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$764.9 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.5% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.3% CAGR.

Global Pharmaceutical Quality Control Market - Key Trends & Drivers Summarized

Why Is Quality Control Emerging as the Cornerstone of Pharmaceutical Manufacturing Success?

In the highly regulated pharmaceutical sector, quality control (QC) is fundamental to safeguarding product efficacy, safety, and regulatory compliance. It encompasses a range of activities including raw material testing, in-process sampling, finished product analysis, and environmental monitoring-ensuring that each batch meets rigorous pharmacopoeial standards and predefined specifications. As regulatory agencies tighten oversight on manufacturing practices and product quality, QC processes are being strengthened through analytical technology, risk-based protocols, and digital integration.

The complexity of modern drug products-particularly biologics, vaccines, and cell and gene therapies-demands highly sensitive and specialized QC methods to monitor critical quality attributes (CQAs). This is prompting the widespread adoption of high-performance liquid chromatography (HPLC), spectroscopy, mass spectrometry, and rapid microbiological methods in QC laboratories. Moreover, the emphasis on real-time release testing (RTRT) and continuous process verification is pushing quality control from a final checkpoint to an integrated, proactive quality assurance function across the entire production cycle.

How Are Advanced Analytical Technologies and Automation Enhancing QC Efficiency and Accuracy?

The integration of advanced analytical instruments and automated workflows is transforming pharmaceutical quality control from a labor-intensive, batch-driven model into a streamlined, high-throughput operation. Automation of sample preparation, data acquisition, and result reporting is reducing turnaround times, minimizing human error, and enhancing traceability. Robotic sampling systems, intelligent data analysis platforms, and LIMS integration are allowing laboratories to process larger volumes with greater accuracy and regulatory compliance.

Technologies such as near-infrared (NIR) spectroscopy, Raman spectroscopy, and chemometric modeling are enabling real-time, non-destructive analysis for solid dosage forms and biopharmaceuticals. Process analytical technology (PAT) tools embedded in manufacturing lines are now being used to monitor and control CQAs in real time, reducing reliance on end-point testing. These innovations are particularly crucial in continuous manufacturing and personalized medicine, where batch sizes are small, timelines are compressed, and product consistency is critical.

Why Are Global Regulations, Cost Pressures, and Digitalization Trends Reshaping QC Strategies?

Regulatory requirements from the FDA, EMA, and WHO are evolving toward quality-by-design (QbD) and lifecycle-based approaches, encouraging companies to integrate QC data with upstream and downstream process control. Authorities now expect robust documentation of testing methodologies, data traceability, and evidence of control strategies in real time. These shifts are prompting pharmaceutical firms to embed QC systems within digital quality management platforms that centralize compliance tracking and support remote audits.

Cost pressures in pharmaceutical production are also influencing QC strategy, particularly for generics and contract manufacturing operations. Companies are investing in multi-analyte platforms, centralized testing facilities, and remote data review systems to optimize resource utilization without compromising quality. Digital transformation is enabling predictive analytics, trend detection, and deviation management through AI and machine learning tools-creating a proactive and adaptive QC function that goes beyond traditional quality assurance paradigms.

What’s Driving the Global Growth of the Pharmaceutical Quality Control Market?

The growth in the pharmaceutical quality control market is driven by several factors including rising drug complexity, evolving regulatory frameworks, and the shift toward continuous and precision manufacturing. A major growth driver is the need to ensure product integrity, patient safety, and compliance in the face of global supply chain diversification and fast-paced innovation cycles.

As the industry scales up biologics, biosimilars, and advanced therapies, the demand for accurate, sensitive, and standardized QC technologies is escalating. At the same time, globalization of drug production and outsourcing trends are creating a need for harmonized, validated quality control systems across geographies. The expansion of digital quality ecosystems, automation technologies, and rapid analytical methods will continue to support the evolution of QC into a strategic function-central to risk mitigation, regulatory success, and operational excellence in pharmaceutical manufacturing worldwide.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Quality Control market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instruments, Services); Analysis Type (Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing, Raw Material Testing, Other Analysis Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• bioMerieux SA
• BRAM-COR SPA
• Charles River Laboratories International Inc.
• Danaher Corporation
• Esco Micro Pte. Ltd.
• Eurofins Scientific
• Lucideon Limited
• Merck KGaA
• Mettler Toledo
• Panomex Inc.
• PerkinElmer Inc.
• REMI Group
• Sartorius AG
• SGS S.A.
• Shimadzu Scientific Instruments
• Solvias AG
• Thermo Fisher Scientific Inc.
• Toxikon Corporation
• Waters Corporation
• WuXi AppTec

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Pharmaceutical Quality Control - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Regulatory Emphasis on Product Purity and Compliance Drives Investment in Advanced Quality Control Systems
  • Expansion of Biologics and Biosimilars Throws the Spotlight on Specialized Analytical Testing Capabilities
  • OEM Innovation in Rapid Microbiological and Non-Destructive Testing Enhances Throughput in QC Labs
  • Growth in Global Contract Manufacturing Spurs Demand for Harmonized Quality Control Protocols
  • OEM Development of Cloud-Based QC Data Platforms Supports Real-Time Monitoring and Decision Making
  • Increasing Use of Automated Sampling and Inline Testing Drives Quality Control Efficiency and Repeatability
  • OEM Integration With LIMS and ERP Platforms Enhances Traceability and Batch Release Compliance
  • Surge in Demand for High-Potency APIs and Cytotoxic Compounds Requires Specialized Containment and QC Environments
  • OEM Collaboration With CROs and CDMOs Strengthens Standardization of QC Frameworks Across Networks
  • Rising Importance of Data Integrity and GxP Compliance Spurs Digitalization of QC Documentation
  • OEM Focus on AI-Driven Root Cause Analysis and Statistical Quality Control Improves Failure Prevention
  • Expansion of PAT and QbD Approaches Supports Risk-Based Quality Control in Continuous Manufacturing
  • OEM Participation in Global Pharmacopoeia Harmonization Initiatives Enhances Analytical Consistency
  • Increasing Emphasis on Elemental Impurities and Residual Solvent Testing Expands Analytical Scope
  • OEM Development of Portable and Handheld QC Instruments Supports Rapid Point-of-Need Testing
  • Growth in Environmental Monitoring in Aseptic Manufacturing Enhances Demand for Cleanroom QC Tools
  • OEM Advances in Chromatography, Mass Spectrometry, and Spectroscopy Drive Complex Molecule Analysis
  • Rising Complexity of Combination Products and Drug-Device Systems Drives Integrated QC Approaches
  • OEM Entry Into Digital Validation and Qualification Platforms Reduces Audit Burden and Compliance Timelines
  • Global Supply Chain Disruptions Emphasize the Need for Decentralized and Redundant QC Operations
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pharmaceutical Quality Control Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pharmaceutical Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Pharmaceutical Quality Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Analysis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Analysis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Analysis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Sterility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Sterility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Sterility Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Bioburden Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Bioburden Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Bioburden Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Endotoxin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Endotoxin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Endotoxin Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Stability Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Stability Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Stability Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Extractable & Leachable Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Extractable & Leachable Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Extractable & Leachable Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Raw Material Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Raw Material Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Raw Material Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• JAPAN
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• CHINA
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: China 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• EUROPE
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Pharmaceutical Quality Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Europe 15-Year Perspective for Pharmaceutical Quality Control by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Europe 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• FRANCE
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 68: France Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: France Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: France 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 71: France Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: France Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: France 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• GERMANY
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 74: Germany Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Germany Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Germany 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 77: Germany Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Germany Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Germany 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 80: Italy Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Italy Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Italy 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 83: Italy Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Italy Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Italy 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 86: UK Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: UK Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: UK 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 89: UK Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: UK Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: UK 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 92: Spain Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Spain Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Spain 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 95: Spain Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Spain Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Spain 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 98: Russia Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Russia Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Russia 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 101: Russia Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Russia Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Russia 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Rest of Europe Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Rest of Europe 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Rest of Europe Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Rest of Europe 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 111: Asia-Pacific Historic Review for Pharmaceutical Quality Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Asia-Pacific 15-Year Perspective for Pharmaceutical Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Asia-Pacific Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Asia-Pacific 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Asia-Pacific Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Asia-Pacific 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 119: Australia Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Australia Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Australia 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 122: Australia Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Australia Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Australia 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• INDIA
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 125: India Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: India Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: India 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 128: India Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: India Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: India 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 131: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: South Korea Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: South Korea 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 134: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: South Korea Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: South Korea 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Asia-Pacific Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Asia-Pacific Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 143: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 144: Latin America Historic Review for Pharmaceutical Quality Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Latin America 15-Year Perspective for Pharmaceutical Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 146: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Latin America Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Latin America 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 149: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Latin America Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Latin America 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 152: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Argentina Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Argentina 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 155: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Argentina Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Argentina 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 158: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Brazil Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Brazil 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 161: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Brazil Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Brazil 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 164: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Mexico Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Mexico 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 167: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Mexico Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Mexico 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Rest of Latin America Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Rest of Latin America 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Latin America Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Latin America 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 176: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 177: Middle East Historic Review for Pharmaceutical Quality Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Middle East 15-Year Perspective for Pharmaceutical Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 179: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Middle East Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Middle East 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 182: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Middle East Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Middle East 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 185: Iran Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Iran Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Iran 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 188: Iran Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Iran Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Iran 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 191: Israel Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Israel Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Israel 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 194: Israel Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Israel Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Israel 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Saudi Arabia Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Saudi Arabia 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Saudi Arabia Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Saudi Arabia 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 203: UAE Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: UAE Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: UAE 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 206: UAE Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: UAE Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: UAE 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Middle East Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Rest of Middle East 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Rest of Middle East Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Rest of Middle East 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030
• AFRICA
  • Pharmaceutical Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 215: Africa Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Africa Historic Review for Pharmaceutical Quality Control by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Africa 15-Year Perspective for Pharmaceutical Quality Control by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2015, 2025 & 2030
  • TABLE 218: Africa Recent Past, Current & Future Analysis for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Africa Historic Review for Pharmaceutical Quality Control by Analysis Type - Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Africa 15-Year Perspective for Pharmaceutical Quality Control by Analysis Type - Percentage Breakdown of Value Sales for Other Analysis Types, Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing and Raw Material Testing for the Years 2015, 2025 & 2030

IV. COMPETITION